BACKGROUND Previous meta-analyses have investigated the relative safety and efficacy profiles of different types of
RESULTS
The flow diagram of the study analysis is shown in Online Figure 1 . Of 2,815 potentially relevant articles initially screened, 51 trials met the inclusion criteria and were included in the final meta-analysis, with a total of 52,158 randomized patients. The evidence network is shown in Figure 1 . The major characteristics of the included trials appear in Table 1 . Median follow-up (determined as described previously) was 3.8 years (range 3 to 6 years) (27) . The major inclusion and exclusion criteria and internal validity assessment for each trial are reported in Online Table 1 .
The clinical characteristics of patients enrolled in the RCTs included in the meta-analysis are reported in Online Table 2 . Updated RCTs with extended followup compared with prior reports are shown in Online Table 3 .
LONG-TERM ST. As shown in Figure 2 and Table 2 , at a median follow-up duration of 3.8 years, CoCr-EES Table 3 ). Re-ZES, PC-ZES, and SES were associated with lower rates of MI than PES.
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PC-ZES also were associated with borderline significant reductions in cardiac death and MI compared with BMS. All DES were associated with lower rates of TVR than BMS. In addition, CoCr-EES, PtCr-EES, SES, and BES were associated with lower rates of TVR than PES, and CoCr-EES were associated with a borderline reduction in TVR compared with PC-ZES.
The number of adverse events associated with each stent type in pooled pairwise comparisons is reported in Online Table 5 .
DISCUSSION
With a median follow-up of nearly 4 years, the present study is the largest, most comprehensive report to date comparing the long-term safety and efficacy between different types of DES and between DES and BMS. The principal finding is that secondgeneration DES have eliminated the late safety issues that became apparent with first-generation DES, and even demonstrate a substantially improved late safety and efficacy profile compared with BMS.
Specifically, 1) CoCr-EES were associated with lower rates of long-term definite ST than BMS, PES, SES, and BES, whereas PC-ZES were associated with lower rates of definite ST than SES; 2) CoCr-EES were associated with lower rates of long-term death than BMS, PES, and SES and with lower rates of MI than BMS, SES, and PES, whereas PC-ZES, SES, and Re-ZES were associated with significantly lower rates of MI than PES; and 3) all DES were associated with significantly lower rates of TVR than BMS; in addition, CoCr-EES, SES, PtCr-EES, and BES were associated with lower rates of TVR than PES, and CoCr-EES had lower rates of TVR than PC-ZES (Central Illustration). To address these issues, we undertook the present large-scale, comprehensive network meta-analysis, which included 51 RCTs with more than 50,000 randomized patients with $3 year follow-up. The present analysis has substantially increased the period of surveillance after stent implantation from a median of 1.7 years in previous reports (7, 31) Re-ZES vs. Values are hazard ratio (95% credible interval). Statistically significant comparisons are highlighted in bold.
Abbreviations as in Table 1 . 
